Clear all search history
Law & Crime
Disasters & Accidents
War & Conflict
Hospitality & Recreation
donepezil articles over last 30 days
articles last 30 days
articles per day
Mentioned in this news
£3.5 million for Exeter team's national health te...
... considered new evidence on the effectiveness and cost-effectiveness of the drugs
, rivastigmine, galantamine and memantine in the treatment of Alzheimer’s disease. The...
Read more at This is West Country
National Institute for Health and Care Excellence
Leave no one behind in Alzheimer’s research
... must: •Be 55-85 years old, with mild to moderate Alzheimer’s disease •Be receiving
(Aricept) treatment for at least 6 months •Live in the community (not a nursing...
Read more at Del Mar Times
U.S. Food and Drug Administration
Targacept Phase 2b Clinical Trial in Alzheimer’s ...
Alzheimer’s disease. In the trial, TC-1734 did not meet the objective of showing superiority to
, the marketed medication most often prescribed for Alzheimer’s disease, after 52 weeks of...
Read more at Business Wire
Securities and Exchange Commission
Latest from Twitter
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.